A Phase 1 Study to Evaluate the Pharmacokinetics of LY2605541 Injection and Insulin Lispro Injection Administered as Mixture or as Individual Components in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 24 Oct 2014
At a glance
- Drugs Insulin peglispro (Primary) ; Insulin lispro
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Eli Lilly
- 20 Oct 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 04 Mar 2014 Planned End Date changed from 1 Sep 2014 to 1 Mar 2015 as reported by ClinicalTrials.gov.
- 16 Dec 2013 Planned end date changed from 1 Mar 2014 to 1 Sep 2014 as reported by ClinicalTrials.gov.